ENDRA Life Sciences’ $5.5 Million Common Stock Offering

Sichenzia Ross Ference LLP represented ThinkEquity in the offering.

ENDRA Life Sciences (NASDAQ: NDRA) executed a public offering of the common stock, which consisted of 7,857,286 shares of common stock, and the gross proceeds from the offering were $5,500,100, before deducting underwriting discounts and estimated offering expenses.

ENDRA Life Sciences is a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care.

The Sichenzia Ross Ference LLP team advising ThinkEquity, a division of Fordham Financial Management, as sole underwriter, was led by partners Gregory Sichenzia (Picture), Darrin Ocasio, Barrett DiPaolo and associate Jacob Tabman.

Involved fees earner: Barrett DiPaolo – Sichenzia Ross Ference LLP; Darrin Ocasio – Sichenzia Ross Ference LLP; Gregory Sichenzia – Sichenzia Ross Ference LLP; Jacob Tabman – Sichenzia Ross Ference LLP;

Law Firms: Sichenzia Ross Ference LLP;

Clients: ThinkEquity;


Author: Ambrogio Visconti